Christa Pike up and walking — will she sue after the botched execution?

Christa Pike, the only woman on Tennessee's death row, has become the center of an unprecedented legal and medical saga after surviving a botched execution attempt. Given two lethal doses of a drug that failed to kill her, Pike is now recovering at Vanderbilt Medical Center, raising profound questions about her future, the state's execution protocols, and the very nature of capital punishment.

The Predictable Failure of Lethal Injection

Dr. John Zivit, an anesthesiologist hired by Pike's defense team, had warned against lethal injection for Pike long before the incident. His review of hundreds of pages of her medical records revealed several critical issues. Pike has a known history of difficult IV access, meaning she is a "difficult stick" with small veins, making the placement of the two functional intravenous lines required for lethal injection technically challenging. Furthermore, Tennessee has a documented history of struggling with IV access in executions, as seen in the case of Tony Kurthers, where a physician failed to place a central line after multiple attempts.

A third, and perhaps most critical, factor is Pike's condition of thrombocytosis, an overproduction of platelets that increases her blood's tendency to clot. Dr. Zivit predicted that once a vein was punctured, the body's natural response would be to form a clot, obstructing the IV. This is precisely what he believes happened: the IVs burst, the catheters moved, and the veins ruptured, causing most of the pentobarbital to be injected into her forearm rather than her central circulation. This, combined with potential issues regarding the quality or potency of the pentobarbital, led to the execution's failure. Dr. Zivit emphasizes that this was not a "miracle" but the "ordinariness of failure" within a flawed system.